Assessment of minimal residual disease in childhood non-hodgkin lymphoma by polymerase chain reaction using patient-specific primers.

Sabesan V, Cairo MS, Lones MA, Perkins SL, Morris E, Sposto R, Van De Ven C, Shiramizu B. Assessment of minimal residual disease in childhood non-hodgkin lymphoma by polymerase chain reaction using patient-specific primers. J Pediatr Hematol Oncol. 2003 Feb; 25(2):109-13.

View in: PubMed

subject areas

Adolescent
Burkitt Lymphoma
Child
Child, Preschool
DNA Primers
DNA, Neoplasm
Feasibility Studies
Female
Genes, T-Cell Receptor delta
Genes, T-Cell Receptor gamma
Humans
Immunoglobulin Heavy Chains
Infant
Lymphoma, Non-Hodgkin
Lymphoma, T-Cell
Male
Neoplasm, Residual
Polymerase Chain Reaction

authors with profiles

Bruce Shiramizu, MD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support